The Austedo approval is notable for two reasons: One, it is the first deuterated drug (i.e., a drug containing the stable isotope — deuterium — in place of a hydrogen atom) to be approved by ...

Vertex acquired the deuterated drug from Concert Pharmaceuticals in 2017 for $160 million up front and up to $90 million in milestones. The FDA approved the new combination therapy on the basis of ...

I remind readers that a deuterated drug is a molecule in which a hydrogen atom has been replaced by a deuterium atom; deuteration is a common approach in drug discovery. Cybin states that CYB003 ...

It is the first deuterated drug to be reviewed by the FDA, Teva noted. No further clinical trials were needed, so Teva has been able to re-file quickly, and the FDA has set a decision date of ...

although various other partly deuterated benzenes, together with hexadeuterobenzene, had been examined. The s-tri-derivative has now been made (m.p. 6·1°).

“Looking ahead, we are excited about Cybin’s next phase of investigation and growth and for the upcoming milestones, including a readout of topline efficacy data from our CYB004 Phase 2 GAD study in ...

Cybin (NYSE American: CYBN) (Cboe CA: CYBN) is a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developin ...